AFJKR (AFJKR)

Current Report Filed: 2026-04-21

Aimei Health Technology received a Nasdaq delisting notice on April 17, 2026, for failing to file its 2025 Annual Report on Form 10-K by the March 31, 2026 deadline, creating immediate compliance risk.
The company has 60 calendar days to file the delayed Annual Report or submit a remediation plan to Nasdaq; acceptance of a plan could extend the timeline to 180 days from the original due date, though no assurances are provided.
The delisting notice has no immediate effect on trading, but failure to regain compliance will result in automatic delisting from Nasdaq, which could significantly impact liquidity and stock price.
The company filed a Form 12b-25 notification of late filing on April 1, 2026, indicating prior awareness of filing delays, and management states it is 'working diligently' to complete the Annual Report with expected timely compliance.

Current Report Filed: 2026-04-07

Aimei Health Technology Co., Ltd. has extended the deadline to complete its initial business combination by one month, from April 6, 2026 to May 6, 2026.
The company has secured an extension payment of $34,330.96 from its sponsors, Aimei Health Ltd and United Hydrogen Group Inc., in the form of an unsecured promissory note.
The promissory note gives the sponsors the right, but not the obligation, to convert the note into private units of the company immediately prior to the consummation of the business combination.

Important Information